Detalhe da pesquisa
1.
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Strahlenther Onkol;
197(1): 48-55, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33001241
2.
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.
Strahlenther Onkol;
197(9): 802-811, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33320286
3.
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5year results of a phase II study.
Strahlenther Onkol;
193(9): 733-741, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28500491
4.
Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.
Ann Surg Oncol;
21(4): 1352-60, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24306667
5.
Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).
Strahlenther Onkol;
190(7): 646-53, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24737540
6.
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Breast;
64: 136-142, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35691249
7.
[Not Available]. / Was muss ich tun, um eine klinische Studie starten zu können?
Klin Monbl Augenheilkd;
233(1): 17-20, 2016 Jan.
Artigo
em Alemão
| MEDLINE
| ID: mdl-27195328
8.
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA).
Clin Transl Radiat Oncol;
28: 90-96, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33912695
9.
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
Int J Radiat Oncol Biol Phys;
70(4): 1081-6, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17881150
10.
Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.
Radiat Oncol;
12(1): 138, 2017 Aug 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28821268
11.
[What do I have to do to start my clinical study?]. / Was muss ich tun, um eine klinische Studie starten zu können?
Dtsch Med Wochenschr;
140(18): 1368-71, 2015 Sep.
Artigo
em Alemão
| MEDLINE
| ID: mdl-26360949
12.
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
Radiat Oncol;
8: 90, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23587311
13.
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases.
Radiat Oncol;
8: 162, 2013 Jul 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23822663
14.
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.
Int J Radiat Oncol Biol Phys;
87(5): 992-9, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24210078
15.
Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study.
Radiat Oncol;
7: 83, 2012 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22681700
16.
Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.
Breast Care (Basel);
6(5): 363-368, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22619646
17.
Margins! Margins. Margins? How Important Is Margin Status in Breast-Preserving Therapy?
Breast Care (Basel);
6(5): 359-362, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22619645
18.
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.
Clin Cancer Res;
17(10): 3469-77, 2011 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21558395
19.
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.
Clin Cancer Res;
17(15): 5161-9, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21673069
20.
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
Int J Radiat Oncol Biol Phys;
78(2): 472-8, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20133081